Alert iconWarning: Unsupported web browser

In View no longer supports your current web browser version, which means some functionality may be limited. Please update your browser for the best experience before you log in.

close icon
Citi Private Bank logo

Unsupported browser

Our website no longer supports your current web browser version, which means you are no longer able to access this website. Please update your browser to continue.

Investment strategy
April 19, 2021
2 mins

UK and European equities continue to look attractive

April 19, 2021
2 mins
Jeffrey Sacks

With vaccine rollout progress and economic recovery continuing, we see reasons to accumulate both UK and European equities.

Overweight UK equities: UK equities are cheap in absolute and relative terms and offer attractive dividend yields. The rapid vaccine rollout along with ongoing fiscal and monetary policy support should lead to a strong GDP growth rebound this year. In turn, average EPS growth may approach 40%. Early logistical and administrative challenges from leaving the EU are no worse than expected. We believe that early challenges in implementing the Northern Ireland protocol will be overcome.

Overweight European equities: The patchy vaccine rollout is starting to improve in the present quarter. European Central Bank (ECB) policy remains very supportive, while the EU Recovery Fund implementation is likely to gather momentum over the summer. The Biden presidency should be a net positive factor for Europe. Alternative energy is a powerful long-term growth driver, supported by increasingly ambitious government initiatives. Italy’s new PM Draghi -the former ECB chairman – is positive for Italy and more broadly for all the periphery countries and for European solidarity.

Both UK and European equities offer particularly good exposure to the areas we favour globally: COVID cyclicals, value, mid-caps, high dividend yielders and dividend growers.

Close Contact Form
Close Modal

You're about to leave the Citi Private Bank website

By clicking continue, you will visit a third-party website that is not owned or managed by us.

We have no control of the content, privacy or security beyond this point.


Stay on this page